Osborne Partners Capital Management’s Alerian MLP Index ETNs due January 28 2044 AMJB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.6M Sell
364,721
-3,231
-0.9% -$113K 0.7% 44
2026
Q1
$12.7M Sell
367,952
-677
-0.2% -$22.6K 0.67% 47
2025
Q4
$11M Sell
368,629
-6,636
-2% -$197K 0.57% 63
2025
Q3
$11.1M Sell
375,265
-4,116
-1% -$125K 0.56% 65
2025
Q2
$11.5M Sell
379,381
-7,256
-2% -$219K 0.61% 61
2025
Q1
$12.6M Sell
386,637
-6,848
-2% -$219K 0.72% 47
2024
Q4
$11.6M Sell
393,485
-9,877
-2% -$290K 0.67% 51
2024
Q3
$11.5M Sell
403,362
-9,605
-2% -$275K 0.65% 56
2024
Q2
$12M Buy
+412,967
New +$11.6M 0.72% 48

Other funds holding AMJB

Osborne Partners Capital Management's AMJB Position: Q2 2026 in Review

Osborne Partners Capital Management reduced its Alerian MLP Index ETNs due January 28 2044 (AMJB) stake by 0.88% in Q2 2026, selling an estimated $113K and leaving 364,721 shares worth $12.6M. The position accounts for 0.7% of the portfolio, ranked #44.

Osborne Partners Capital Management first reported a position in AMJB in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.7M in Q1 2026. 73 funds tracked by Wall St. Rank hold AMJB as of Q2 2026.

  • Osborne Partners Capital Management held 364,721 shares of Alerian MLP Index ETNs due January 28 2044 worth $12.6M as of Q2 2026.
  • Osborne Partners Capital Management sold 3,231 Alerian MLP Index ETNs due January 28 2044 shares in Q2 2026, an estimated $113K.
  • Alerian MLP Index ETNs due January 28 2044 made up 0.7% of Osborne Partners Capital Management's portfolio in Q2 2026, its #44 holding.
  • Osborne Partners Capital Management first reported a position in Alerian MLP Index ETNs due January 28 2044 in Q2 2024 and has held it in 9 quarters since.
  • Osborne Partners Capital Management's Alerian MLP Index ETNs due January 28 2044 position peaked at $12.7M in Q1 2026.
  • 73 funds tracked by Wall St. Rank held Alerian MLP Index ETNs due January 28 2044 as of Q2 2026.

Based on Osborne Partners Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.